Refractory cases of myasthenia gravis can be relieved by a new treatment based on replacing a patient’s immune system with new one created from transplants of his own stem cells, Canadian researchers report.
Carolyn Colwell
Advertisement
Articles by Carolyn Colwell
Advertisement
Latest Updated Articles
Stem Cell Therapy for Myasthenia GravisPublished: April 11th 2016 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program
5
